menu toggle

Unlocking the Future of Healthcare: The EU Health Technology Assessment (HTA) Journey

As the European Union takes bold strides towards harmonizing and enhancing its healthcare landscape, the imminent implementation of the Joint Clinical Assessment (JCA) stands as a pivotal moment. With less than 1 year remaining until its full integration, we invite you to explore a wealth of insights that delve deep into the intricacies of this transformative initiative.

Unveiling the path forward, our experts offer unparalleled insights into the current status of JCA and shed light on the uncertainties that lie ahead, and the solutions to help you navigate those.

One expert partner, from global strategy to local implementation

We invest in understanding your situation to provide a tailored solution that empowers global patient access.
AB-Customer-Service-Female_RGB_Large_JPG

Achieve local reimbursement globally

We can help you devise a global strategy and then tailor it to the unique requirements of each market for a coordinated and thoughtful approach to access.
Examining data on a tablet

Maximize product value

We go beyond the average partner as experts in both market access strategy and generating the evidence (i.e., we can be both scientific in our thinking and commercial in our approach).
implementation of the new EU JCA

Navigate Health Technology Assessments (HTAs)

We work through the complex HTA processes in different countries, helping our clients’ products meet the specific requirements of each assessment.
Does EU HTAR put patients at the center

Insight

From PICO anxiety to PICO strategy: planning for EU HTA success

Ruairi O'Donnell, PhD
AmerisourceBergen
July 2024

professionals around computer monitor

Insight

Navigating new access hurdles in Europe: A conversation with Cencora’s EU HTA Lead

Ruairi O'Donnell, PhD
AmerisourceBergen
March 2024

PageDesign_Patient_Doc

Insight

Webinar on demand: Implications of the EU JCA on patient access and engagement


AmerisourceBergen
November 2023

Insight

Panel discussion: The EU JCA process

Seeking to substitute multiple country-specific clinical assessments and establish a more streamlined, transparent and less bureaucratic single market for health technologies, the EU JCA will pose both a threat and an opportunity for getting innovative medicines to patients in Europe.

Watch our panel discussion with EFPIA, MSD, PharmaLex and Vintura to explore the ins and outs of the JCA and the next steps to best prepare.

Insight

Q&A – Preparing for the EU Joint Clinical Assessment (JCA) process

During a panel discussion on the European Joint Clinical Assessment (JCA) process, led by Tommy Bramley, Senior Vice President, Global Consulting and Market Access, Cencora, market access and healthcare system experts offered their perspectives on the challenges and opportunities pharmaceutical and biotechnology companies are likely to encounter. In this article, panelists delve into the questions received from the audience.

Insight

Navigating the way to the new EU JCA—Are biopharma companies, HTA bodies, patients, and clinicians sufficiently prepared? 

The interim period between the closure of the European Network for Health Technology Assessment 21 (EUnetHTA 21) and the full application of the Health Technology Assessment Regulation (HTAR) has begun. Is sufficient guidance available for biopharma companies, health technology assessment (HTA) bodies, patients, and clinicians, or do uncertainties remain?

Where to meet us?

Join us at an exciting series of industry conferences including Pharma Europe, ISPOR US 2024 and ISPOR Europe 2024  to discuss how we can help you navigate the EU HTA and accelerate patient’s speed to therapy.
jca eu hta

Insight

Panel explores insights and implications of the game-changing EU JCA


AmerisourceBergen
July 2023

insights into the workings of the JCA process

Insight

Podcast: Collaborative perseverance to bring change to medicine access


AmerisourceBergen
August 2023

Group Physicians Wearing Masks

Insight

Multistakeholder perspectives on Joint Clinical Assessment in Europe


AmerisourceBergen
August 2023

Contact us

Contact us today to schedule a consultation and discover how we can help your business achieve global market access and sustainable growth.
MeetingConfRoomGroupLarge11160106RGBLargeJPG